Huntington’s Disease Treatment Market is expected to reach US$ 2,033.41 million by 2033 from US$ 512.88 million in 2024, with a CAGR of 16.54% from 2025 to 2033. Some of the main drivers propelling the market include the growing prevalence of Huntington\'s disease, the expanding need for cutting-edge medications to treat the condition, and the recent emergence of novel therapy techniques.